208 related articles for article (PubMed ID: 34862277)
1. Time trends in access to smoking cessation support for people with depression or severe mental illness: a cohort study in English primary care.
Falcaro M; Osborn D; Hayes J; Coyle G; Couperthwaite L; Weich S; Walters KR
BMJ Open; 2021 Dec; 11(12):e048341. PubMed ID: 34862277
[TBL] [Abstract][Full Text] [Related]
2. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
[TBL] [Abstract][Full Text] [Related]
3. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Perceptions and Smoking Cessation Experiences Between Smokers With and Without Serious Mental Illness in a Large Health Maintenance Organization.
Kertes J; Neumark Y; Grunhaus L; Stein-Reisner O
J Dual Diagn; 2021; 17(4):284-295. PubMed ID: 34651553
[TBL] [Abstract][Full Text] [Related]
5. Cigarette Smoking and Quitting-Related Factors Among US Adult Health Center Patients with Serious Mental Illness.
Kalkhoran S; Thorndike AN; Rigotti NA; Fung V; Baggett TP
J Gen Intern Med; 2019 Jun; 34(6):986-991. PubMed ID: 30783880
[TBL] [Abstract][Full Text] [Related]
6. Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink.
Davies NM; Taylor AE; Taylor GM; Itani T; Jones T; Martin RM; Munafò MR; Windmeijer F; Thomas KH
Health Technol Assess; 2020 Feb; 24(9):1-46. PubMed ID: 32079557
[TBL] [Abstract][Full Text] [Related]
7. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
8. The delivery of smoking cessation interventions to primary care patients with mental health problems.
Szatkowski L; McNeill A
Addiction; 2013 Aug; 108(8):1487-94. PubMed ID: 23534846
[TBL] [Abstract][Full Text] [Related]
9. The relationship between smoking cessation and binge drinking, depression, and anxiety symptoms among smokers with serious mental illness.
Hammett PJ; Lando HA; Taylor BC; Widome R; Erickson DJ; Joseph AM; Clothier B; Fu SS
Drug Alcohol Depend; 2019 Jan; 194():128-135. PubMed ID: 30439609
[TBL] [Abstract][Full Text] [Related]
10. Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.
Vilardaga R; Rizo J; Palenski PE; Mannelli P; Oliver JA; Mcclernon FJ
Nicotine Tob Res; 2020 Aug; 22(9):1533-1542. PubMed ID: 31667501
[TBL] [Abstract][Full Text] [Related]
11. Smoking cessation for improving mental health.
Taylor GM; Lindson N; Farley A; Leinberger-Jabari A; Sawyer K; Te Water Naudé R; Theodoulou A; King N; Burke C; Aveyard P
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013522. PubMed ID: 33687070
[TBL] [Abstract][Full Text] [Related]
12. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
Gilbody S; Peckham E; Bailey D; Arundel C; Heron P; Crosland S; Fairhurst C; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C
Lancet Psychiatry; 2019 May; 6(5):379-390. PubMed ID: 30975539
[TBL] [Abstract][Full Text] [Related]
13. Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers.
Shewale AR; Borse MS; Brown JD; Li C
Drug Alcohol Depend; 2015 Sep; 154():132-8. PubMed ID: 26169448
[TBL] [Abstract][Full Text] [Related]
14. Australian mental health care practitioners' practices and attitudes for encouraging smoking cessation and tobacco harm reduction in smokers with severe mental illness.
Sharma R; Meurk C; Bell S; Ford P; Gartner C
Int J Ment Health Nurs; 2018 Feb; 27(1):247-257. PubMed ID: 28160384
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.
Bullen C; Verbiest M; Galea-Singer S; Kurdziel T; Laking G; Newcombe D; Parag V; Walker N
BMC Public Health; 2018 May; 18(1):596. PubMed ID: 29728074
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness.
Japuntich SJ; Hammett PJ; Rogers ES; Fu S; Burgess DJ; El Shahawy O; Melzer AC; Noorbaloochi S; Krebs P; Sherman SE
Nicotine Tob Res; 2020 Aug; 22(9):1433-1438. PubMed ID: 31957794
[TBL] [Abstract][Full Text] [Related]
17. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Smoking Cessation Program Registration, Participation, Smoking Cessation Medication Utilization, and Abstinence Rates Between Smokers With and Without Schizophrenia, Schizo-affective Disorder, or Bipolar Disorder.
Kertes J; Stein Reisner O; Grunhaus L; Nezry R; Alcalay T; Azuri J; Neumark Y
Nicotine Tob Res; 2022 Mar; 24(5):670-678. PubMed ID: 34626108
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]